These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34915126)

  • 81. Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts.
    Garousi J; Huizing FJ; Vorobyeva A; Mitran B; Andersson KG; Leitao CD; Frejd FY; Löfblom J; Bussink J; Orlova A; Heskamp S; Tolmachev V
    Sci Rep; 2019 Oct; 9(1):14907. PubMed ID: 31624303
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Role of the CD137 ligand (CD137L) signaling pathway during Mycobacterium tuberculosis infection.
    Martínez Gómez JM; Koh VH; Yan B; Lin W; Ang ML; Rahim SZ; Pethe K; Schwarz H; Alonso S
    Immunobiology; 2014 Jan; 219(1):78-86. PubMed ID: 24091276
    [TBL] [Abstract][Full Text] [Related]  

  • 83. DC-CTL targeting carbonic anhydrase IX gene combined with iAPA therapy in the treatment of renal cell carcinoma.
    Ma H; Tan Y; Wen D; Qu N; Kong Q; Li K; Ma S; Zhang J
    Hum Vaccin Immunother; 2021 Nov; 17(11):4363-4373. PubMed ID: 34851805
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccine.
    Zhou X; Jun DY; Thomas AM; Huang X; Huang LQ; Mautner J; Mo W; Robbins PF; Pardoll DM; Jaffee EM
    Cancer Res; 2005 Feb; 65(3):1079-88. PubMed ID: 15705910
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Synergistic antitumor responses by combined GITR activation and sunitinib in metastatic renal cell carcinoma.
    Yu N; Fu S; Xu Z; Liu Y; Hao J; Zhang A; Wang B
    Int J Cancer; 2016 Jan; 138(2):451-62. PubMed ID: 26239999
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Combination therapy with dendritic cell-based vaccine and anti-CD69 antibody enhances antitumor efficacy in renal cell carcinoma-bearing mice.
    Wei SM; Pan HL; Wang L; Yin GL; Zhong K; Zhou Y; Yang SJ; Xin ZL
    Turk J Med Sci; 2017 Apr; 47(2):658-667. PubMed ID: 28425263
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma.
    Driessens G; Hoffmann P; Pouwels M; Zlotta A; Schulman C; Velu T; Bruyns CA
    J Immunother; 2009; 32(2):140-4. PubMed ID: 19238012
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Targeting CAIX with [
    Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z
    Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity.
    Tanegashima T; Togashi Y; Azuma K; Kawahara A; Ideguchi K; Sugiyama D; Kinoshita F; Akiba J; Kashiwagi E; Takeuchi A; Irie T; Tatsugami K; Hoshino T; Eto M; Nishikawa H
    Clin Cancer Res; 2019 Aug; 25(15):4808-4819. PubMed ID: 31076547
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Preclinical Evaluation of virus-like particle Vaccine Against Carbonic Anhydrase IX Efficacy in a Mouse Breast Cancer Model System.
    Kalniņa Z; Liekniņa I; Skeltona V; Akopjana I; Kazāks A; Tārs K
    Mol Biotechnol; 2024 May; 66(5):1206-1219. PubMed ID: 38217826
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Adenovirus-mediated interleukin-2 production by tumors induces growth of cytotoxic tumor-infiltrating lymphocytes against human renal cell carcinoma.
    Mulders P; Tso CL; Pang S; Kaboo R; McBride WH; Hinkel A; Gitlitz B; Dannull J; Figlin R; Belldegrun A
    J Immunother; 1998 May; 21(3):170-80. PubMed ID: 9610908
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccine.
    Gigante M; Blasi A; Loverre A; Mancini V; Battaglia M; Selvaggi FP; Maiorano E; Napoli A; Castellano G; Storkus WJ; Gesualdo L; Ranieri E
    Mol Immunol; 2009 Feb; 46(5):893-901. PubMed ID: 19041139
    [TBL] [Abstract][Full Text] [Related]  

  • 94. CD4+ T-cell recognition of human 5T4 oncofoetal antigen: implications for initial depletion of CD25+ T cells.
    Elkord E; Burt DJ; Drijfhout JW; Hawkins RE; Stern PL
    Cancer Immunol Immunother; 2008 Jun; 57(6):833-47. PubMed ID: 18004564
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Carbonic Anhydrase IX in Renal Cell Carcinoma, Implications for Disease Management.
    Courcier J; de la Taille A; Nourieh M; Leguerney I; Lassau N; Ingels A
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998233
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP; Weng YS; Wu QQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinoma.
    Buchner A; Pohla H; Willimsky G; Frankenberger B; Frank R; Baur-Melnyk A; Siebels M; Stief CG; Hofstetter A; Kopp J; Pezzutto A; Blankenstein T; Oberneder R; Schendel DJ
    Hum Gene Ther; 2010 Mar; 21(3):285-97. PubMed ID: 19788391
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Anti-4-1BB scFv immunogene therapy and low dose cyclophosphamide exhibit a synergistic antitumor effect in established murine lung tumors.
    Liu F; Fang C; Ye X; Lu Q; Yu DH; Zhang WW; Qi H; Xie J; Lieber A; Chen HZ
    Cancer Biol Ther; 2009 Apr; 8(8):707-13. PubMed ID: 19417562
    [TBL] [Abstract][Full Text] [Related]  

  • 99. CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma.
    James BR; Anderson KG; Brincks EL; Kucaba TA; Norian LA; Masopust D; Griffith TS
    Cancer Immunol Immunother; 2014 Nov; 63(11):1213-27. PubMed ID: 25143233
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Combined natural killer T-cell based immunotherapy eradicates established tumors in mice.
    Teng MW; Westwood JA; Darcy PK; Sharkey J; Tsuji M; Franck RW; Porcelli SA; Besra GS; Takeda K; Yagita H; Kershaw MH; Smyth MJ
    Cancer Res; 2007 Aug; 67(15):7495-504. PubMed ID: 17671220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.